novel von hippel-lindau syndrome therapies inhibiting hif-2α
Published 1 year ago • 66 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
4:44
pathophysiology and management of von hippel-lindau syndrome
-
9:35
litespark-004: 36 month follow-up of belzutifan in von hippel-lindau syndrome
-
5:20
treatment strategies for von hippel-lindau syndrome
-
1:41
von hippel lindau syndrome | genetics | common presentation
-
1:59
what is von hippel-lindau syndrome?
-
5:28
von hipple-lindau disease ( vhl ) - case based discussion usmle
-
1:19
von hippel lindau disease
-
58:42
"von hippel-lindau disease", a scientific lecture by nobel laureate william g. kaelin
-
5:06
what is von hippel-lindau disease? one patient's vhl story - the vhl alliance
-
16:26
learn about ocular von hippel-lindau disease with dr. henry wiley
-
28:42
living with huntington's disease
-
1:48
dr. jonasch on next steps with mk-6482 in von hippel-lindau disease–associated rcc
-
13:17
belzutifan for von hippel-lindau syndrome
-
4:53
data from von-hippel-lindau clinical trial shows promise for hif-2a inhibitor
-
22:38
von hippel-lindau disease: clinical update and new drug therapy
-
6:46
von hippel lindau syndrome
-
2:48
oral hif-2 α inhibitor mk-6482 in patients with advanced clear cell renal cell carcinoma
-
1:25
a-hipi, a novel prognostic model for advanced hl & outcomes of elderly patients with hl in australia
-
22:38
von hippel-lindau disease: clinical update and new drug therapy
-
3:58
nancy rose spector's rare disease story
-
1:16
dr. jonasch on the safety profile of mk-6482 in von hippel-lindau disease–associated rcc
-
2:21
phase ii study of the oral hif-2α inhibitor mk-6482